What Does Health Care Reform Mean for People Concerned About Colorectal Cancer?

This morning, the President signed into law the biggest transformation of our health care system in decades.  The law includes a number of provisions that will help individuals diagnosed with colon or rectal cancer.

Although many of the provisions of the new law are phased in to take effect gradually until the entire law is implemented in 2018, some benefits will be available immediately.

Highlights of the provisions that will benefit individuals people facing cancer treatment include: prohibiting insurance companies from dropping patients who become sick; eliminating lifetime and annual limits on coverage; prohibiting insurance companies from denying coverage because of pre-existing conditions; and limits on on out-of-pocket expenses.

You can review a chart developed by C3 with key issues affecting colorectal cancer prevention and treatment that are part of the health care reform legislation.

While historic, enactment of this new law is just one step in an ongoing process.  Even after all the provisions in the new law take effect in 2018, many Americans may be newly insured but will still fail to receive the right treatment at the right time.  The Colorectal Cancer Coalition continues to support research to help develop new treatments and to support efforts to increase awareness about the importance of early detection and screening. Continue reading…

Posted by Kate Murphy on March 23rd, 2010
Posted in: Policy & Advocacy News, Research & Treatment News | 1 Comment »
Tags: colorectal cancer, colorectal cancer prevention, Health Care Reform

Aspirin Saves Lives after Colon Cancer Treatment

Photo by Mara Zemgaliete

Colorectal cancer patients with early stage disease were 30 percent less likely to die from cancer and 20 percent less likely to die at all if they took aspirin regularly after their diagnosis.

Benefit was even greater for those who began taking the medicine for the first time after their diagnosis.

However, only the group whose tumors tested positive for COX-2 (cyclooxygenase2) benefited from aspirin.   Continue reading…

Posted by Kate Murphy on August 13th, 2009
Posted in: Research & Treatment News | 6 Comments »
Tags: aspirin, colorectal cancer, survival